Patents by Inventor Rajat SHAH
Rajat SHAH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240090519Abstract: The present invention provides a solid, non-hygroscopic curing agent in a powdered/granular form easy to use, handle and optionally reconstitute, comprising a plant-based nitrite derived from a concentrated liquid extract obtained from plant material selected from Beet, radish, onion, celery and chicory leaf. In particular, it relates to a plant-based nitrite derived from a concentrated liquid extract obtained from plant material celery. The non-hygroscopic powder/granular agent has an excellent solid-state stability, longer shelf-life, easy to package and store. It can be used to preserve or cure meat or meat products and also has other applications in the food industry.Type: ApplicationFiled: June 8, 2021Publication date: March 21, 2024Inventors: Vishal SHAH, Rajat SHAH, Sanjay SINGH
-
Publication number: 20240058412Abstract: The invention describes a modified release formulation comprising 2 to 10% withanolides, obtained from root powder of Withania somnifera. The formulation is comprised of at least one pH independent release controlling agent or the combination thereof. The invention also provides a process for preparation of modified release composition; wherein Ashwagandha root powder enriched with withanolides is uniformly dispersed and embedded throughout the matrix of at least one pH independent release controlling agent. The granules can be conveniently formulated in suitable compressible dosage forms, filled in sachets or capsules for oral administration. The formulation may release more than 75% of withanolides over a period of 6 to 12 hours. The modified release formulation may be useful for maintaining significant concentration of withanolides in blood plasma over extended time and can be administered to the subjects in need thereof for stress management, cognitive benefits and improving overall mental well-being.Type: ApplicationFiled: August 17, 2022Publication date: February 22, 2024Inventors: Vishal SHAH, Rajat SHAH, Shajahan ABDUL
-
Publication number: 20240024246Abstract: The invention relates to stable prolonged release vitamin C formulation, which is free of any added stabilizer and exhibits prolonged release of the active. The formulation is comprised of at least one hydrophobic non-polymeric excipient and hydrophilic release controlling agent along with at least one excipient. The invention also relates to the process for preparation, wherein the active may be treated with hydrophobic release controlling agent, followed by aqueous granulation with hydrophilic release controlling agent. The granules can be converted into compressible dosage forms like tablets or filled in capsules or sachets. The formulation is stable and releases more than 85% of vitamin C over a period of 8 to 24 hours. The formulation can be suitably orally administered to the subjects in need thereof, for maintaining effective levels of vitamin C over prolonged time.Type: ApplicationFiled: August 24, 2021Publication date: January 25, 2024Inventors: Rajat SHAH, Vishal SHAH, Shajahan ABDUL
-
Publication number: 20230293696Abstract: The present invention relates to a melt composite comprising one or more curcuminoids and a carrier selected from rice bran extract, mannitol, maltodextrin and mixtures thereof. The invention also provides a process for preparation of the melt composite, wherein the mixture of curcuminoids, rice bran extract, mannitol, maltodextrin and mixture thereof may be subjected to controlled conditions of heating and granulation. The melt composite may also be optionally comprised of one more excipient suitable for use for human consumption. Curcuminoid composites can be formulated in suitable solid, liquid or semisolid compositions. Curcuminoid composites and the compositions thereof, exhibit rapid dissolution and enhanced bioavailability.Type: ApplicationFiled: April 20, 2023Publication date: September 21, 2023Inventors: Vaibhavi SHAH, Vijayendrakumar REDASANI, Shajahan ABDUL, Vishal SHAH, Rajat SHAH
-
Publication number: 20230225389Abstract: The present invention relates to a prolonged release formulation of caffeine, which comprises of caffeine embedded in a continuous phase of non-polymeric release controlling carrier. The formulation may be optionally comprised of one or more excipients which are acceptable in nutraceutical and food industry. The invention also relates to a process for preparation; wherein caffeine is uniformly distributed throughout the continuous phase of non-polymeric release controlling carrier to get single-phase granules. The formulation releases caffeine through continuous phase of non-polymeric release controlling carrier, wherein about 20 to 60% of caffeine is released in first hour, followed by about 50-90% of release in 4-8 hours and about 70 to 100% of caffeine release in 8-12 hours. Caffeine formulation can advantageously be administered to a subject for achieving stimulant effect through prolonged release of caffeine over entire day.Type: ApplicationFiled: December 11, 2020Publication date: July 20, 2023Inventors: Vishal SHAH, Rajat SHAH, Shajahan ABDUL
-
Patent number: 11666535Abstract: The present invention relates to a melt composite comprising one or more curcuminoids and a carrier selected from rice bran extract, mannitol, maltodextrin and mixtures thereof. The invention also provides a process for preparation of the melt composite, wherein the mixture of curcuminoids, rice bran extract, mannitol, maltodextrin and mixture thereof may be subjected to controlled conditions of heating and granulation. The melt composite may also be optionally comprised of one more excipient suitable for use for human consumption. Curcuminoid composites can be formulated in suitable solid, liquid or semisolid compositions. Curcuminoid composites and the compositions thereof, exhibit rapid dissolution and enhanced bioavailability.Type: GrantFiled: September 25, 2019Date of Patent: June 6, 2023Assignee: INVENTIA HEALTHCARE LIMITEDInventors: Vaibhavi Shah, Vijayendrakumar Redasani, Shajahan Abdul, Vishal Shah, Rajat Shah
-
Publication number: 20220362184Abstract: The invention describes a gut-protective composition comprising boswellic acid, at least one pH modifier, wherein the composition exhibits enhanced dissolution. The composition as described herein may be comprised of about 5 to 95% of boswellic acid. The said composition is stable and exhibits improved bioavailability. The invention also provides a process for preparation of the said composition, wherein boswellic acid and pH modifier are mixed well by optionally adding at least one or more excipient and processed to get granular powder. The composition may be further formulated into solid, semi solid or liquid dosage forms, for administration to human or animals. The compositions described herein exhibit gut-protective effect in conditions of colitis as well as microbial infections.Type: ApplicationFiled: December 23, 2019Publication date: November 17, 2022Inventors: Vaibhavi SHAH, Vijayendrakumar REDASANI, Shajahan ABDUL, Vishal SHAH, Rajat SHAH
-
Publication number: 20220265575Abstract: The invention describes a non-staining composition comprising high content of curcuminoids in granular form, which is substantially free of excipients and is comprised of at least about 94% of curcuminoids. The non-staining composition may be comprised of 0 to 5% by weight of excipients, which are used as processing aids. The non-staining curcuminoid composition does not cause staining and dusting of the equipment and the contact surfaces, while formulating into finished dosage forms. The invention also relates to solvent-free process for preparation of non-staining granular composition; wherein the curcuminoids may be subjected to granulation process at specific temperature conditions. The granular composition is free flowing and retains original yellowish orange colour of the curcuminoids along with its crystalline nature.Type: ApplicationFiled: August 19, 2020Publication date: August 25, 2022Inventors: Vishal SHAH, Rajat SHAH, Manoj TIWARI, Shajahan ABDUL
-
Publication number: 20210330591Abstract: The present invention relates to a melt composite comprising one or more curcuminoids and a carrier selected from rice bran extract, mannitol, maltodextrin and mixtures thereof. The invention also provides a process for preparation of the melt composite, wherein the mixture of curcuminoids, rice bran extract, mannitol, maltodextrin and mixture thereof may be subjected to controlled conditions of heating and granulation. The melt composite may also be optionally comprised of one more excipient suitable for use for human consumption. Curcuminoid composites can be formulated in suitable solid, liquid or semisolid compositions. Curcuminoid composites and the compositions thereof, exhibit rapid dissolution and enhanced bioavailability.Type: ApplicationFiled: September 25, 2019Publication date: October 28, 2021Inventors: Vaibhavi Shah, Vijayendrakumar Redasani, Shajahan Abdul, Vishal Shah, Rajat Shah
-
Publication number: 20180262978Abstract: A small cell includes a transceiver configured to receive and access request from a wireless-enabled device. The small cell also includes a processor configured to selectively provide the wireless-enabled device with private access to an enterprise network and public access to one or more core networks of mobile network operators based on an identifier included in the access request. The wireless-enabled device includes a transceiver configured to receive, from the small cell, broadcast information including an identifier of the enterprise network or the one or more core networks. The wireless-enabled device also includes a processor configured to compare the broadcast information to configuration information stored in the wireless-enabled device. The configuration information includes identifiers of the enterprise network or the core networks. The processor is configured to selectively provide the access request to the small cell based on the comparison.Type: ApplicationFiled: March 9, 2017Publication date: September 13, 2018Inventors: Colin Leon Kahn, Rajiv Narahari, Rajat Shah
-
Publication number: 20080196424Abstract: One embodiment relates to a method for preventing evaporator core freezing in an air conditioning system, comprising determining the occurrence of an evaporator core freezing condition for a first one of a plurality of evaporators. Determining the occurrence of an evaporator core freezing condition may be done without measuring the air out temperature first evaporator. The method also comprises adjusting an operating parameter of the air conditioning system to eliminate the core freezing condition.Type: ApplicationFiled: February 20, 2007Publication date: August 21, 2008Inventors: Rajat SHAH, Richard Obradovich